Disease glycan biomarkers
Glycomic profiles shift in conditions such as cancer and inflammation, and these changes are being explored as diagnostic and prognostic biomarkers, though most require further validation before clinical use.1
Glycome Atlas
Topic
Also known as glycome analysis, glycan profiling
Plain-language answer
Glycomics is the study of all the sugar chains a cell, tissue, or organism makes, taken together as one collection called the glycome. Just as genomics looks at the full set of genes and proteomics at the full set of proteins, glycomics tries to identify and measure the many different carbohydrate structures attached to proteins and fats across a biological sample.12
Sugar chains coat nearly every cell and influence how cells stick together, communicate, and are recognized by the immune system. Because these patterns shift in cancer, infection, and inflammation, mapping the glycome can reveal disease signals that genes and proteins alone do not show, which is why glycomics is a growing source of biomarkers.1
Technical detail
Glycomics is the systematic, large-scale characterization of the glycome, the complete set of glycan structures present in a biological system, using analytical platforms such as mass spectrometry, chromatography, and glycan-binding-protein arrays to define glycan composition, sequence, linkage, and relative abundance.12
Glycomics parallels genomics and proteomics but addresses a fundamentally different kind of molecule. Glycan biosynthesis is not template-driven; the final structures emerge from the combined activity of many glycosyltransferases and glycosidases, nucleotide-sugar availability, and compartmental organization, which generates extensive structural heterogeneity at any single site. As a result the glycome cannot be predicted directly from genomic sequence and must be measured empirically.12
Typical glycomic workflows release glycans enzymatically or chemically from proteins and lipids, or analyze intact glycoconjugates, then separate and detect the structures by mass spectrometry, liquid chromatography, capillary electrophoresis, or lectin-based profiling. Interpretation relies on standardized structure representation and repositories so that assignments can be compared across laboratories.1
Human relevance
Glycomic profiles shift in conditions such as cancer and inflammation, and these changes are being explored as diagnostic and prognostic biomarkers, though most require further validation before clinical use.1
Continue exploring
References